Our team brought Okapi Sciences from a series A in 2008 to a healthy acquisition in 2014. The same team has merged Okapi Sciences’ livestock assets with innovations at Academia to form ViroVet. Currently we are approaching 20 FTE. Our company was elected as 2015 and 2017 startup of the year by Animal Pharm News. You can meet and connect with our board members, the founders and our investors by clicking below.

Board of Directors

Founders

Investors

Chairman

Chairman

George Gunn
CEO

CEO

Erwin Blomsma
for AIF

for AIF

Luc Basstanie
for PMV

for PMV

David Devigne
for VIVES

for VIVES

Filip Goossens
for CSCF

for CSCF

Ludwig Goris
for GFF

for GFF

Pierre Naassens
CEO

CEO

Erwin Blomsma
CDO

CDO

Nesya Goris
COO

COO

Stefaan Wera

Agri Investment Fund

AIF

Biotech Fonds Vlaanderen

PMV

Capricorn Sustainable Chemistry Fund

CSCF

Gemma Frisius Fund

GFF

Louvain Technology Fund

VIVES
  • Twitter Social Icon
  • LinkedIn Social Icon
  • Facebook Social Icon

Copyright (c) ViroVet NV 2019. All rights reserved.